Sirtex Medical logo

SRX - Sirtex Medical Share Price

A$33.55 0.0  0.0%

Last Trade - 13/09/18

Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £123.7m
Position in Universe th / 1899
Unlock SRX Revenue
Relative Strength (%)
1m +2.71%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2013 2014 2015 2016 2017 2018 2019E 2020E CAGR / Avg
99.2 131.2 178 234.7 236.9 220.7 247.2 256.6 +17.3%
+5.8 +29.3 +68.7 +32.2 -37.9 +27.7 +49.9 +7.66
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 30 June 2018, SirtexMedical Limited revenues decreased 7% to A$220.7M. Netincome totaled A$41.5M vs. loss of A$26.3M. Revenuesreflect Americas segment decrease of 4% to A$193M, EMEAsegment decrease of 2% to A$197.7M. Net Income reflectsImpairment of Intangibles Excl. Goodwill decrease fromA$90.5M (expense) to A$0K, Marketing Expenses decrease of17% to A$74.4M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


SRX Revenue Unlock SRX Revenue

Net Income

SRX Net Income Unlock SRX Revenue

Normalised EPS

SRX Normalised EPS Unlock SRX Revenue

PE Ratio Range

SRX PE Ratio Range Unlock SRX Revenue

Dividend Yield Range

SRX Dividend Yield Range Unlock SRX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
SRX EPS Forecasts Unlock SRX Revenue
Profile Summary

Sirtex Medical Limited is a medical device company with primary objective of manufacturing and distributing liver cancer treatments utilizing small particle technology to markets in Asia-Pacific; Europe, the Middle East and Africa (EMEA), and North and South America. The Company's segments include Asia Pacific, Americas and EMEA. Its lead product is SIR-Spheres Y-90 resin microspheres, which is a targeted radioactive treatment for liver cancer. The treatment is called Selective Internal Radiation Therapy (SIRT) and consists of a minimally invasive surgical procedure performed by an interventional radiologist. The SIR-Spheres microspheres lodge in the small blood vessels of the tumor where they destroy it from the inside while sparing the surrounding healthy tissue. The Company is also engaged in conducting other studies, which include SIRFLOX and FOXFIRE Global for liver metastases, and RESIRT for primary renal cell carcinoma. SIR-Spheres is available in over 40 countries.

Last Annual June 30th, 2018
Last Interim June 30th, 2018
Incorporated April 21, 1997
Public Since August 24, 2000
No. of Shareholders: 8,322
No. of Employees: 292
Sector Healthcare
Industry Healthcare Equipment & Supplies
Exchange Australian Stock Exchange - SEATS
Shares in Issue 55,773,045
Free Float (0.0%)
Eligible for
SRX Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for SRX
Upcoming Events for SRX
Frequently Asked Questions for Sirtex Medical
What is the Sirtex Medical share price?

As of 13/09/18, shares in Sirtex Medical are trading at A$33.55, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Sirtex Medical share price performed this year?

Shares in Sirtex Medical are currently trading at A$33.55 and the price has moved by 0.113k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Sirtex Medical price has moved by 60.58% over the past year.

What are the analyst and broker recommendations for Sirtex Medical?

Of the analysts with advisory recommendations for Sirtex Medical, there are there are currently 0 "buy" , 3 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Sirtex Medical is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Sirtex Medical next release its financial results?

Sirtex Medical is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2019-06-30
What is the Sirtex Medical dividend yield?

Sirtex Medical does not currently pay a dividend.

Does Sirtex Medical pay a dividend?

Sirtex Medical does not currently pay a dividend.

When does Sirtex Medical next pay dividends?

Sirtex Medical does not currently pay a dividend.

How do I buy Sirtex Medical shares?

To buy shares in Sirtex Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Sirtex Medical?

Shares in Sirtex Medical are currently trading at A$33.55, giving the company a market capitalisation of £n/a.

Where are Sirtex Medical shares listed? Where are Sirtex Medical shares listed?

Here are the trading details for Sirtex Medical:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: SRX
What kind of share is Sirtex Medical?

We were not able to load our ranking data for Sirtex Medical

Is there a Sirtex Medical share price forecast 2021?

We were not able to load any forecast data for Sirtex Medical.

How can I tell whether the Sirtex Medical share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sirtex Medical. Over the past six months, the relative strength of its shares against the market has been 6.71%. At the current price of A$33.55, shares in Sirtex Medical are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Sirtex Medical PE Ratio?

We were not able to find PE ratio data for Sirtex Medical.

Who are the key directors of Sirtex Medical?

We were unable to find the directors for Sirtex Medical.

Who are the major shareholders of Sirtex Medical?

Here are the top five shareholders of Sirtex Medical based on the size of their shareholding:

Similar to SRX
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.